Related Experiment Video
Updated: May 26, 2026

Bronchoalveolar Lavage (BAL) for Research; Obtaining Adequate Sample Yield
Published on: March 24, 2014
Impact of antimicrobial exposure on bronchoscopy yields in immunocompromised patients: a single-centre experience
Albert Teng1, Deshawn Tan1, Kundan Reddy Saripalli2
1Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.
Background:
Bronchoscopy with bronchoalveolar lavage (BAL) is an important diagnostic tool for pulmonary infections in immunocompromised hosts (ICH). However, the effect of pre-procedural antimicrobial exposure on BAL yield remains uncertain. Our study aimed to evaluate associations between pre-bronchoscopy antimicrobial exposure and BAL microbiological yield.
Methods:
We analysed data from a prospective registry of immunocompromised patients undergoing bronchoscopy with BAL at a tertiary hospital between May 2021 and May 2024. Positive BAL yield was defined as positive bacterial or fungal culture, viral polymerase chain reaction (PCR), or BAL galactomannan (GM) >0.5. Associations between antimicrobial exposure and BAL yield were analysed.
Results:
A total of 113 bronchoscopies were performed in 107 ICH. Prior to bronchoscopy, 85% had received antibiotics, 41.6% antivirals, and 26.5% antifungals. BAL yielded at least one positive result in 76.1% of procedures, including bacterial cultures (23.0%), fungal cultures (67.3%), viral PCR (27.4%), and GM >0.5 (15.0%). Prophylactic antibiotics [odds ratio (OR) 0.168, 95% confidence interval (CI): 0.037-0.762, P=0.01] and empiric antibiotics ≥24 h (OR 0.262, 95% CI: 0.100-0.687, P=0.005) were associated with reduced bacterial culture yield. Prophylactic antifungal exposure reduced fungal culture yield (OR 0.206, 95% CI: 0.073-0.584, P=0.002). Conversely, antiviral exposure increased odds of positive viral PCR (OR 2.997, 95% CI: 1.274-7.051, P=0.01), while empiric antifungals ≥48 h increased odds of positive GM (OR 9.538, 95% CI: 1.915-47.505, P=0.01).
Conclusions:
Pre-bronchoscopy exposure to antibiotics and antifungals was associated with reduced bacterial and fungal yields respectively, supporting the value of early BAL. Viral PCR and GM assays remained informative despite antimicrobial exposure. The perceived reduction in yield should be weighed against the persistent diagnostic utility of BAL, especially for viral and fungal pathogens.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microbiota of the Respiratory Tract
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features